申请人:Mammen Mathai
公开号:US20130323271A1
公开(公告)日:2013-12-05
In one aspect, the invention relates to compounds having the formula:
where R
1
, R
2
, R
3
, R
7
, R
8
, Z, X, b, and c are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds are nitric oxide donors and have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.
在一方面,本发明涉及具有以下公式的化合物:其中R1、R2、R3、R7、R8、Z、X、b和c按说明书定义,或其药用可接受的盐。这些化合物是氧化氮供体并具有中性内肽酶抑制活性。在另一方面,本发明涉及包含此类化合物的药物组合物;使用此类化合物的方法;以及制备此类化合物的过程和中间体。